Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Chelsee J. Jensen"'
Autor:
Aakash P, Desai, Caleb J, Scheckel, Leah C, Soderberg, Chelsee J, Jensen, Jacob J, Orme, Sri H, Tella, Anuhya, Kommalapati, Joshua C, Pritchett, Nandita, Khera, Amit, Mahipal, Ronald S, Go
Publikováno v:
JCO Oncology Practice. 18:e1247-e1254
PURPOSE: Precision oncology promises improved outcomes but the cost-effectiveness and accessibility of targeted therapies is debatable. We report price change patterns from 2015 to 2019 for several oral anticancer medications for common solid tumor m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d69943c2553d56c6fd6577b53d75bd45
https://doi.org/10.1200/op.21.00847
https://doi.org/10.1200/op.21.00847
Autor:
Chelsee J. Jensen, Eric M. Tichy, Mary B. Lempke, Adam M. Ewald, Sara J. Erickson, Michelle R. Holm, Scott A. Soefje
Publikováno v:
Mayo Clinic proceedings. 97(6)
To determine whether the formation of a multidisciplinary team, pharmacist-led therapeutic interchange, and streamlined electronic health record optimization improved biosimilar adoption throughout Mayo Clinic.The project focused on the use of refere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b486a0aebf560b34df08ba775e59b98
https://pubmed.ncbi.nlm.nih.gov/35662421
https://pubmed.ncbi.nlm.nih.gov/35662421
Autor:
Aakash Desai, Caleb Scheckel, Chelsee J. Jensen, Jacob Orme, Colt Williams, Nilay Shah, Konstantinos Leventakos, Alex A. Adjei
Publikováno v:
JAMA Network Open
This cross-sectional study examines trends in costs of brand-name medications for treatment of non–small cell lung cancer and within-class price differences between these medications in the US from 2015 to 2020.
Key Points Question How did the
Key Points Question How did the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60d74d06ff18a3a203744aeb64327764
https://doi.org/10.1001/jamanetworkopen.2021.44923
https://doi.org/10.1001/jamanetworkopen.2021.44923